Post-translational Modification of Pregnane X Receptor
dc.contributor.author | Staudinger, Jeffrey Leonard | |
dc.contributor.author | Xu, Chenshu | |
dc.contributor.author | Biswas, Arunima | |
dc.contributor.author | Mani, Sridhar | |
dc.date.accessioned | 2017-05-08T20:39:14Z | |
dc.date.available | 2017-05-08T20:39:14Z | |
dc.date.issued | 2011-03-21 | |
dc.identifier.citation | Staudinger, Jeff L. et al. “Post-Translational Modification of Pregnane X Receptor.” Pharmacological research : the official journal of the Italian Pharmacological Society 64.1 (2011): 4–10. | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/24030 | |
dc.description.abstract | Pregnane x receptor (PXR, NR1I2) was originally characterized as a broad spectrum entero-hepatic xenobiotic ‘sensor’ and master-regulator of drug inducible gene expression. A compelling description of ligand-mediated gene activation has been unveiled in the last decade that firmly establishes this receptor’s central role in the metabolism and transport of xenobiotics in mammals. Interestingly, pharmacotherapy with potent PXR ligands produces several profound side effects including decreased capacities for gluconeogenesis, lipid metabolism, and inflammation; likely due to PXR-mediated repression of gene expression programs underlying these pivotal physiological functions. An integrated model is emerging that reveals a sophisticated interplay between ligand binding and the ubiquitylation, phosphorylation, SUMOylation, and acetylation status of this important nuclear receptor protein. These discoveries point to a key role for the post-translational modification of PXR in the selective suppression of gene expression, and open the door to the study of completely new modes of regulation of the biological activity of PXR. | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ | |
dc.subject | Pregnane x receptor | en_US |
dc.subject | Post-translational modification | en_US |
dc.title | Post-translational Modification of Pregnane X Receptor | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Staudinger, Jeff L. | |
kusw.kudepartment | Pharmacology & Toxicology | en_US |
dc.identifier.doi | 10.1016/j.phrs.2011.02.011 | en_US |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.identifier.pmid | PMC3111031 | en_US |
dc.rights.accessrights | openAccess |
Files in this item
This item appears in the following Collection(s)
-
Pharmacy Scholarly Works [293]
Except where otherwise noted, this item's license is described as: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.